Exclusive: Danaher’s venture arm backs cell therapy manufacturing startup co-founded by Carl June
Danaher Ventures, the venture arm of the life sciences giant Danaher, is investing $18 million into a startup co-founded by Carl June that aims to make cheaper, faster cell therapies.
Novalis LifeSciences and Marshall Wace also participated in the seed round for BlueWhale Bio, which comes out of the University of Pennsylvania.
June, whose research led to the development of CAR-T cell therapy to treat cancer, and Penn professor James Riley are co-inventors of the technology that is the basis of BlueWhale’s platform. June is also a member of Danaher’s scientific advisory board.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.